ResMed Inc. (RMD)
NYSE
Closed
Aug 24, 2026
Day's Range
229.9352 wk Range
180.27Overview - RMD - ResMed Inc.
Key Statistics
Valuation
Enterprise Value
32.75B
P/E (Trailing)
‪22.17‬
P/E (Forward)
‪17.51‬
PEG Ratio
‪9.57‬
Price / Sales (TTM)
‪5.90‬
Price / Book
‪5.08‬
EV / EBITDA
‪15.62‬
Profitability
Profit Margin
‪26.94%‬
Operating Margin
‪30.85%‬
Return on Assets
‪14.00%‬
Return on Equity
‪24.26%‬
Ownership
Shares Outstanding
144.25M
Float
143.36M
Short % of Shares Outstanding
‪12.45%‬
Held by Insiders
‪0.49%‬
Held by Institutions
‪71.62%‬
Price stats
Beta
‪0.74‬
50-Day Avg
‪206.94‬
200-Day Avg
‪229.13‬
Dividends
Payout Ratio
‪23.01%‬
Frequency
Quarterly
Analyst Consensus
18 analysts
Average price target
‪$ 247.20‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RMD - ResMed Inc.
Peers - RMD - ResMed Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - RMD - ResMed Inc.
About
ResMed Inc. is a healthcare company that develops and supplies digital health technologies and cloud-connected medical devices for respiratory care. Its core products support the treatment of sleep apnea, COPD, and other chronic diseases through flow generators, masks, and related accessories used in home-based and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
